In a major stride toward unearthing one of state’s largest public health procurement scams, the State Economic Offences Investigation Agency and Anti-Corruption Bureau (SEOIACB) on Saturday filed a voluminous chargesheet spanning nearly 18,000 pages against six key accused involved in the Chhattisgarh Medical Services Corporation (CGMSC) scam. The chargesheet was presented before the Special Court (Prevention of Corruption Act) in Raipur, formally indicting Shashank Chopra (Director/Partner, Mokshit Medicare Pvt. Ltd.) and other CGMSC officials name Basant Kumar Kaushik; Kshirodra Rautia;

 

Dr. Anil Parsai; Kamlakant Patanwar; and Deepak Kumar Bandhe. According to the investigation, the accused individuals, in collusion, orchestrated a meticulously planned criminal conspiracy to defraud the State by manipulating tendering procedures under the ‘Hamar Lab’ scheme. This scheme was intended to facilitate free diagnostic services across district hospitals, FRUs, CHCs, PHCs, and sub-health centers for the public. The accused allegedly engaged in pooled tendering and procured medical reagents and equipment far in excess of the actual requirement, resulting in gross misuse of public funds. Investigators estimate that their actions inflicted an economic loss of approximately Rs 550 crore on the State exchequer, violating Sections 409 and 120B of the IPC, along with Sections 13(1)(a), 13(2), and 7(c) of the Prevention of Corruption Act, 1988 (as amended in 2018).

 

The chargesheet meticulously outlines how unnecessary and inflated procurements were systematically sanctioned, with key decision-makers at CGMSC allegedly receiving unlawful benefits. It also tracks the financial flows, forged documentation, tender rigging patterns, and blatant abuse of authority. SEOIACB officials, while confirming the filing of the chargesheet, stated that this move marks a critical milestone but added that the investigation remains ongoing to unearth the broader conspiracy network. Sources indicated that further supplementary chargesheets could be filed as new evidence surfaces, particularly regarding the role of additional suppliers and facilitators who enabled the siphoning off of public health funds.